Baldassarri, Stephen R. https://orcid.org/0000-0002-5928-3733
Chu, Jen-hwa
Deng, Annan
Xu, Zhichao
Blohowiak, Reagan F.
Byrne, Sean
Kushida, Clete
Yaggi, H. Klar
Zinchuk, Andrey
Funding for this research was provided by:
National Institute on Drug Abuse (K23DA045957)
National Heart, Lung, and Blood Institute (K23HL159259)
Article History
Received: 14 December 2022
Revised: 22 February 2023
Accepted: 7 April 2023
First Online: 14 April 2023
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (name of institute/committee) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The original study was approved by the institutional review board (IRB) at each of the clinical sites including: Stanford University, Stanford, CA; University of Arizona, Tucson, AZ; Providence St. Mary Medical Center, Walla Walla, WA; St. Luke's Hospital, Chesterfield, MO; and Brigham and Women's Hospital, Boston, MA. For this type of study involving deidentified data, formal consent and IRB approval were not required.
: All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.